Incremental Prognostic Value of Conventional Echocardiography in Patients with Acutely Decompensated Heart Failure

Fabio Luis de Jesus Soares, Janine Magalhães Garcia de Oliveira, Gabriel Neimann da Cunha Freire, Lucas Carvalho Andrade, Marcia Maria Noya-Rabelo, Luis Claudio Lemos Correia, Fabio Luis de Jesus Soares, Janine Magalhães Garcia de Oliveira, Gabriel Neimann da Cunha Freire, Lucas Carvalho Andrade, Marcia Maria Noya-Rabelo, Luis Claudio Lemos Correia

Abstract

Background: Acutely decompensated heart failure (ADHF) presents high morbidity and mortality in spite of therapeutic advance. Identifying factors of worst prognosis is important to improve assistance during the hospital phase and follow-up after discharge. The use of echocardiography for diagnosis and therapeutic guidance has been of great utility in clinical practice. However, it is not clear if it could also be useful for risk determination and classification in patients with ADHF and if it is capable of adding prognostic value to a clinical score (OPTIMIZE-HF).

Objective: To identify the echocardiographic variables with independent prognostic value and to test their incremental value to a clinical score.

Methods: Prospective cohort of patients consecutively admitted between January 2013 and January 2015, with diagnosis of acutely decompensated heart failure, followed up to 60 days after discharge. Inclusion criteria were raised plasma level of NT-proBNP (> 450 pg/ml for patients under 50 years of age or NT-proBNP > 900 pg/ml for patients over 50 years of age) and at least one of the signs and symptoms: dyspnea at rest, low cardiac output or signs of right-sided HF. The primary outcome was the composite of death and readmission for decompensated heart failure within 60 days.

Results: Study participants included 110 individuals with average age of 68 ± 16 years, 55% male. The most frequent causes of decompensation (51%) were transgression of the diet and irregular use of medication. Reduced ejection fraction (<40%) was present in 47% of cases, and the NT-proBNP median was 3947 (IIQ = 2370 to 7000). In multivariate analysis, out of the 16 echocardiographic variables studied, only pulmonary artery systolic pressure remained as an independent predictor, but it did not significantly increment the C-statistic of the OPTMIZE-HF score.

Conclusion: The addition of echocardiographic variables to the OPTIMIZE-HF score, with the exception of left ventricular ejection fraction, did not improve its prognostic accuracy concerning cardiovascular events (death or readmission) within 60 days.

Conflict of interest statement

Potential Conflict of Interest

No potential conflict of interest relevant to this article was reported.

Figures

Figure 1
Figure 1
Comparison between ROC curves and C-statistics between the OPTIMIZE-HF conventional and combined (OPTIMIZE-HF+PSAP) probabilistic models, using the DeLong test

References

    1. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14(8):603–669. doi: 10.1093/eurjhf/hfs105.
    1. Fonarow GC. The treatment target in acute decompensated heart failure. Rev Cardiovasc Med. 2001;2(Suppl 2):s7–s12.
    1. American Heart Association . Heart and stroke statistical update. Dallas(USA): AHA; 2002. Available from: .
    1. Schocken DD, Benjamin EJ, Fonarow GC, Krumholz HM, Levy D, Mensah GA, et al. Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation. 2008;117(19):2544–2565. doi: 10.1161/CIRCULATIONAHA.107.188965.
    1. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360(14):1418–1428. doi: 10.1056/NEJMsa.0803563.
    1. O'Connor CM, Hasselblad V, Mehta RH, Tasissa G, Califf RM, Fiuzat M, et al. Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score. J Am Coll Cardiol. 2010;55(9):872–878. doi: 10.1016/j.jacc.2009.08.083.
    1. Smith WR, Poses RM, McClish DK, Huber EC, Clemo FL, Alexander D, et al. Prognostic judgments and triage decisions for patients with acute congestive heart failure. Chest. 2002;121(5):1610–1617.
    1. Poses RM, Smith WR, McClish DK, Huber EC, Clemo FL, Schmitt BP, et al. Physicians' survival predictions for patients with acute congestive heart failure. Arch Intern Med. 1997;157(9):1001–1007.
    1. Nagueh SF, Bhatt R, Vivo RP, Krim SR, Sarvari SI, Russell K, et al. Echocardiographic evaluation of hemodynamics in patients with decompensated systolic heart failure. Circ Cardiovasc Imaging. 2011;4(3):220–227. doi: 10.1161/CIRCIMAGING.111.963496.
    1. Carluccio E, Dini FL, Biagioli P, Lauciello R, Simioniuc A, Zuchi C, et al. The 'Echo Heart Failure Score': an echocardiographic risk prediction score of mortality in systolic heart failure. Eur J Heart Fail. 2013;15(8):868–876. doi: 10.1093/eurjhf/hft038.
    1. Giannuzzi P, Temporelli PL, Bosimini E, Silva P, Imparato A, Corra U, et al. Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. J Am Coll Cardiol. 1996;28(2):383–390. doi: 10.1016/0735-1097(96)00163-5.
    1. Grayburn PA, Appleton CP, DeMaria AN, Greenberg B, Lowes B, Oh J, et al. Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST) J Am Coll Cardiol. 2005;45(7):1064–1071. doi: 10.1016/j.jacc.2004.12.069.
    1. Abraham WT, Fonarow GC, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, et al. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) J Am Coll Cardiol. 2008;52(5):347–356. doi: 10.1016/j.jacc.2008.04.028.
    1. Kalogeropoulos AP, Georgiopoulou VV, Gheorghiade M, Butler J. Echocardiographic evaluation of left ventricular structure and function: new modalities and potential applications in clinical trials. J Card Fail. 2012;18(2):159–172. doi: 10.1016/j.cardfail.2011.10.019.
    1. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012:The–The. doi: 10.1093/eurheartj/ehs104.
    1. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39. doi: 10.1016/j.echo.2014.10.003.
    1. Rudski LG, Lai WW. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography Endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685–713. doi: 10.1016/j.echo.2010.05.010.
    1. Montera MW, Almeida RA, Tinoco EM, Rocha RM, Moura LZ, Réa-Neto A, Sociedade Brasileira de Cardiologia II Brazilian Guidelines on Acute Cardiac Insufficiency. Arq Bras Cardiol. 2009;93(3) Suppl 3:1–65.
    1. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF/AHA Guideline for the Management of Heart Failure: a Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128(16):e240–e327. doi: 10.1161/CIR.0b013e31829e8776.
    1. Senni M, Rodeheffer RJ, Tribouilloy CM, Evans JM, Jacobsen SJ, Bailey KR, et al. Use of echocardiography in the management of congestive heart failure in the community. J Am Coll Cardiol. 1999;33(1):164–170.
    1. Grayburn PA, Appleton CP, DeMaria AN, Greenberg B, Lowes B, Oh J, et al. BEST Trial Echocardiographic Substudy Investigators. Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST) J Am Coll Cardiol. 2005;45(7):1064–1071. doi: 10.1016/j.jacc.2004.12.069.
    1. Wong M, Staszewsky L, Latini R, Barlera S, Volpi A, Chiang YT, et al. Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study. J Am Coll Cardiol. 2002;40(5):970–975.
    1. Quinones MA, Greenberg BH, Kopelen HA, Koilpillai C, Limacher MC, Shindler DM, et al. Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricula hypertrophy. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 2000;35(5):1237–1244.
    1. Rossi A, Cicoira M, Bonapace S, Golia G, Zanolla L, Franceschini L, et al. Left atrial volume provides independent and incremental information compared with exercise tolerance parameters in patients with heart failure and left ventricular systolic dysfunction. Heart. 2007;93(11):1420–1425. doi: 10.1136/hrt.2006.101261.
    1. Pinamonti B, Di Lenarda A, Sinagra G, Camerini F. Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and hemodynamic correlations and prognostic implications. Heart Muscle Disease Study Group. J Am Coll Cardiol. 1993;22(3):808–815.
    1. Ghio S, Recusani F, Klersy C, Sebastiani R, Laudisa ML, Campana C, et al. Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol. 2000;85(7):837–842.
    1. Dokainish H, Zoghbi WA, Lakkis NM, Ambriz E, Patel R, Quinones MA, et al. Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol. 2005;45(8):1223–1226. doi: 10.1016/j.jacc.2005.01.025.
    1. Wang M, Yip G, Yu C-M, Zhang Q, Zhang Y, Tse D, et al. Independent and incremental prognostic value of early mitral annulus velocity in patients with impaired left ventricular systolic function. J Am Coll Cardiol. 2005;45(2):272–277. doi: 10.1016/j.jacc.2004.09.059.
    1. Adamopoulos C, Zannad F, Fay R, Mebazaa A, Cohen-Solal A, Guize L, et al. Ejection fraction and blood pressure are important and interactive predictors of 4-week mortality in severe acute heart failure. Eur J Heart Fail. 2007;9(9):935–941. doi: 10.1016/j.ejheart.200706.001..
    1. Hirata K, Hyodo E, Hozumi T, Kita R, Hirose M, Sakanoue Y, et al. Usefulness of a combination of systolic function by left ventricular ejection fraction and diastolic function by E/E' to predict prognosis in patients with heart failure. Am J Cardiol. 2009;103(9):1275–1279. doi: 10.1016/j.amjcard.2009.01.024.
    1. Wang M, Yip GW, Wang AY, Zhang Y, Ho PY, Tse MK, et al. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol. 2003;41(5):820–826.
    1. Shah RV, Chen-Tournoux AA, Picard MH, van Kimmenade RR, Januzzi JL. Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure. Eur J Heart Fail. 2010;12(8):826–832. doi: 10.1093/euryhf/hfg091.
    1. Porter TR, Shillcutt SK, Adams MS, Desjardins G, Glas KE, Olson JJ, et al. Guidelines for the use of echocardiography as a monitor for therapeutic intervention in adults: a report from the American Society of Echocardiography. J Am Soc Echocardiogr. 2015;28(1):40–56. doi: 10.1016/j.echo.2014.09.009.
    1. Arques S, Roux E, Ambrosi P, Sbragia P, Gelisse R, Pieri B, et al. Accuracy of bedside tissue Doppler echocardiography for the prediction of in-hospital mortality in elderly patients with acute heart failure with preserved left ventricular systolic function. comparison with B-type natriuretic peptide measurement. Int J Cardiol. 2007;123(1):69–72. doi: 10.1016/j.ijcard.2006.11.094.
    1. Georgiopoulou VV, Kalogeropoulos AP, Borlaug BA, Gheorghiade M, Butler J. Left ventricular dysfunction with pulmonary hypertension: Part 1: epidemiology,pathophysiology, and definitions. Circ Heart Fail. 2013;6(2):344–354. doi: 10.1161/CIRCHEARTFAILURE.112.000095.
    1. Aronson D, Darawsha W, Atamna A, Kaplan M, Makhoul BF, Mutlak D, et al. Pulmonary hypertension, right ventricular function, and clinical outcome in acute decompensated heart failure. J Card Fail. 2013;19(10):665–671. doi: 10.1016/j.card.fail.2013.08.007.
    1. Merlos P, Núñez J, Sanchis J, Minana G, Palau P, Bodi V, et al. Echocardiographic estimation of pulmonary arterial systolic pressure in acute heart failure: prognostic implications. Eur J Intern Med. 2013;24(6):562–567. doi: 10.1016/j.ejim.2013.04.009.
    1. Gripp EA, Sousa AS, Mendes FS, Marinho TAS, Garcia MI, Feijó LA. Preditores ecocardiográficos de mortalidade hospitalar na insuficiência cardíaca descompensada: valor adicional ao escore ADHERE. Rev Bras Cardiol. 2012;25(6):479–488.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir